The concern of generic competition has long loomed above copyright’s iconic drug, Viagra, triggering questions about the outlook of similar medicinal holdings. While first years saw substantial profits, the intellectual property end has created the path for discounted substitutes, potentially lowering profitability and creating a genuine hazard f